Novalgin

Novalgin is owned by Sanofi S.A., headquartered in France. No. The ultimate owner of Novalgin, Sanofi S.A., is headquartered in France, not in the United States.

Sanofi is a French multinational pharmaceutical and healthcare company, being one of the world's largest by sales, focusing on therapeutic areas such as cardiovascular, central nervous system, and oncology.

Sanofi-Aventis Deutschland GmbH